Trial intelligence / Profile preview

Impact of Pertussis Vaccination in Pregnancy

NCT01698346Phase 4Completed

Sponsor
University of Antwerp
Start
Feb 2012
Primary completion
Dec 2015
Modality
Vaccines & Immunotherapeutics
Countries
2
01

Overview

A Phase 4 trial of acellular pertussis vaccine in pertussis, sponsored by University of Antwerp. Started Feb 2012; status: completed.

02

Drugs

acellular pertussis vaccine
03

Conditions

pertussis

Beyond the preview

Go deeper on NCT01698346.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01698346.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call